This inventor holds 1 USPTO granted patent and 15 published patent applications and 4 EPO patents. Top assignee: Redona Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Thomas Radimerski: Innovator in Cancer Treatment
Introduction: Thomas Radimerski is an inventor based in Tecknau, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and patent applications. Although he currently holds no granted patents, his work reflects a commitment to advancing medical science.
Latest Patent Applications: Thomas Radimerski's latest patent applications include a combination of panobinostat and ruxolitinib in the treatment of cancer, particularly myeloproliferative neoplasm. This invention relates to a combination that aims to enhance therapeutic outcomes for patients. Another notable application is for an isoxazole compound for the treatment of various cancers, including those of the bladder, colon, liver, lung, breast, vagina, ovaries, pancreas, kidney, stomach, gastrointestinal tract, prostate, head and neck, peritoneal cavity, thyroid, bone, brain, central nervous system, and blood. This compound is also intended for treating myelodysplastic syndrome, systemic mastocytosis, von Hippel-Lindau syndrome, multicentric Castleman disease, and psoriasis.
Conclusion: Thomas Radimerski's work in cancer treatment showcases his dedication to innovation in the medical field. His latest patent applications highlight the potential for new therapeutic strategies that could benefit many patients.